| Title : Lactobacillus helveticus R0052-derived membrane vesicles ameliorate DSS-induced inflammatory bowel disease by modulating the gut microbiota and activating the cholinergic anti-inflammatory pathway - Olovo_2026_Int.Immunopharmacol_171_116058 |
| Author(s) : Olovo CV , Ji Y , Ocansey DKW , Huang X , Xu M |
| Ref : Int Immunopharmacol , 171 :116058 , 2026 |
| Abstract : |
| PubMedSearch : Olovo_2026_Int.Immunopharmacol_171_116058 |
| PubMedID: 41512794 |
| Title : Lactobacillus helveticus R0052-derived membrane vesicles ameliorate DSS-induced inflammatory bowel disease by modulating the gut microbiota and activating the cholinergic anti-inflammatory pathway - Olovo_2026_Int.Immunopharmacol_171_116058 |
| Author(s) : Olovo CV , Ji Y , Ocansey DKW , Huang X , Xu M |
| Ref : Int Immunopharmacol , 171 :116058 , 2026 |
| Abstract : |
| PubMedSearch : Olovo_2026_Int.Immunopharmacol_171_116058 |
| PubMedID: 41512794 |
| Title : Lactobacillus helveticus R0052-derived membrane vesicles ameliorate DSS-induced inflammatory bowel disease by modulating the gut microbiota and activating the cholinergic anti-inflammatory pathway - Olovo_2026_Int.Immunopharmacol_171_116058 |
| Author(s) : Olovo CV , Ji Y , Ocansey DKW , Huang X , Xu M |
| Ref : Int Immunopharmacol , 171 :116058 , 2026 |
| Abstract : |
| PubMedSearch : Olovo_2026_Int.Immunopharmacol_171_116058 |
| PubMedID: 41512794 |